Authors: Valentin, L Hagen, B Tingulstad, S Eik-Nes, S

Citation: L. Valentin et al., Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective crossvalidation, ULTRASOUN O, 18(4), 2001, pp. 357-365

Authors: Hogdall, EVS Hogdall, CK Tingulstad, S Hagen, B Nustad, K Xu, FJ Bast, RC Jacobs, IJ

Citation: Evs. Hogdall et al., Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass, INT J CANC, 89(6), 2000, pp. 519-523

Authors: Hagen, B Skjeldestad, FE Halvorsen, T Strickert, T Tingulstad, S Lorenz, E Onsrud, M

Citation: B. Hagen et al., Primary treatment of cervical carcinoma - Ten years experience from one Norwegian health region, ACT OBST SC, 79(12), 2000, pp. 1093-1099

Authors: Lorenz, E Hagen, B Himmelmann, A Kjorstadt, K Onsrud, M Tingulstad, S Gundersen, G

Citation: E. Lorenz et al., A phase II study of biweekly administration of paclitaxel in patients withrecurrent epithelial ovarian cancer, INT J GYN C, 9(5), 1999, pp. 373-376

Authors: Tingulstad, S Hagen, B Skjeldestad, FE Halvorsen, T Nustad, K Onsrud, M

Citation: S. Tingulstad et al., The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals, OBSTET GYN, 93(3), 1999, pp. 448-452